Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,686,936.21
- $30,828,916.57
- March 2, 2026
- Howard G Welgus
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 2, 2026 | Insider | 8,733 | $25.30 | Sell | $220,944.90 | |
| March 2, 2026 | CFO | 2,853 | $25.18 | Sell | $71,838.54 | |
| March 2, 2026 | Insider | 6,287 | $25.18 | Sell | $158,306.66 | |
| March 2, 2026 | Insider | 37,349 | $25.18 | Sell | $940,447.82 | |
| March 2, 2026 | Insider | 3,687 | $25.18 | Sell | $92,838.66 | |
| Feb. 27, 2026 | Insider | 3,325 | $27.95 | Sell | $92,933.75 | |
| Feb. 4, 2026 | Insider | 9,794 | $25.81 | Sell | $252,783.14 | |
| Feb. 2, 2026 | Insider | 19,833 | $25.50 | Sell | $505,741.50 | |
| Feb. 2, 2026 | Director | 10,000 | $25.05 | Sell | $250,500.00 | |
| Feb. 2, 2026 | Insider | 2,052 | $25.50 | Sell | $52,326.00 | |
| Feb. 2, 2026 | Insider | 3,675 | $25.50 | Sell | $93,712.50 | |
| Feb. 2, 2026 | CFO | 1,320 | $25.50 | Sell | $33,660.00 | |
| Sept. 9, 2025 | Insider | 504 | $17.52 | Sell | $8,830.08 | |
| Sept. 8, 2025 | Insider | 9,625 | $17.54 | Sell | $168,822.50 | |
| Sept. 4, 2025 | Insider | 36,130 | $16.16 | Sell | $583,860.80 | |
| Sept. 2, 2025 | Director | 10,000 | $15.64 | Sell | $156,400.00 | |
| Aug. 21, 2025 | Insider | 2,438 | $15.57 | Sell | $37,959.66 | |
| Aug. 19, 2025 | Insider | 1,750 | $16.16 | Sell | $28,280.00 | |
| Aug. 8, 2025 | Insider | 3,847 | $14.03 | Sell | $53,973.41 | |
| Aug. 4, 2025 | Insider | 11,547 | $14.33 | Sell | $165,468.51 | |
| Aug. 4, 2025 | Insider | 6,330 | $14.33 | Sell | $90,708.90 | |
| Aug. 4, 2025 | Insider | 2,622 | $14.33 | Sell | $37,573.26 | |
| Aug. 4, 2025 | CFO | 89 | $14.33 | Sell | $1,275.37 | |
| Aug. 1, 2025 | Director | 10,000 | $14.30 | Sell | $143,000.00 | |
| July 14, 2025 | Insider | 5,750 | $15.07 | Sell | $86,652.50 | |
| July 10, 2025 | Insider | 23,000 | $15.05 | Sell | $346,150.00 | |
| June 18, 2025 | Director | 10,139 | $13.37 | Sell | $135,558.43 | |
| June 13, 2025 | Director | 2,646 | $13.08 | Buy | $34,609.68 | |
| June 5, 2025 | Director | 378 | $13.41 | Buy | $5,068.98 | |
| June 4, 2025 | Director | 1,890 | $13.32 | Buy | $25,174.80 | |
| May 28, 2025 | Insider | 1,800 | $13.78 | Sell | $24,804.00 | |
| May 21, 2025 | Director | 2,520 | $13.66 | Buy | $34,423.20 | |
| May 19, 2025 | Insider | 7,451 | $14.07 | Sell | $104,835.57 | |
| May 8, 2025 | Insider | 3,871 | $13.59 | Sell | $52,606.89 | |
| May 2, 2025 | Insider | 5,030 | $15.20 | Sell | $76,456.00 | |
| March 24, 2025 | Insider | 1,500 | $17.52 | Sell | $26,280.00 | |
| March 17, 2025 | Insider | 1,200 | $17.61 | Sell | $21,132.00 | |
| March 14, 2025 | Insider | 12,242 | $15.04 | Sell | $184,119.68 | |
| March 3, 2025 | Insider | 2,819 | $13.03 | Sell | $36,731.57 | |
| March 3, 2025 | Director | 10,000 | $13.00 | Sell | $130,000.00 | |
| Feb. 3, 2025 | Insider | 8,338 | $12.70 | Sell | $105,892.60 | |
| Feb. 3, 2025 | Director | 10,000 | $12.71 | Sell | $127,100.00 | |
| Jan. 2, 2025 | Director | 10,000 | $14.67 | Sell | $146,700.00 | |
| Dec. 31, 2024 | Insider | 1,691 | $14.00 | Sell | $23,674.00 | |
| Dec. 20, 2024 | Insider | 15,000 | $15.17 | Sell | $227,550.00 | |
| Dec. 2, 2024 | Director | 10,000 | $12.51 | Sell | $125,100.00 | |
| Nov. 30, 2024 | Insider | 1,093 | $7.11 | Buy | $7,771.23 | |
| Nov. 22, 2024 | Insider | 16,023 | $10.14 | Sell | $162,473.22 | |
| Nov. 19, 2024 | Insider | 1,775 | $9.68 | Sell | $17,182.00 | |
| Nov. 15, 2024 | Insider | 100 | $10.03 | Sell | $1,003.00 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Howard G Welgus, Todd Franklin Watanabe, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Larry Todd Edwards, Scott L Burrows, Todd Watanabe, Patricia A Turney, Patrick J Heron, John W. Smither, Orbimed Advisors Llc, Latha Vairavan, Life Sciences Viii L Frazier, David Joseph Topper, Howard G. Welgus, David W Osborne, Watanabe Todd Franklin, David W. Osborne, OSBORNE DAVID W, Jonathan Silverstein, Welgus Howard G., and Terrie Curran
The most active insider trader at Arcutis Biotherapeutics Inc is Howard G Welgus with 31 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on March 2, 2026.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.
